Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Go back to Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.41 | 52 Week High | $9.23 | |||
| Open | $10.41 | 52 Week Low | $1.16 | |||
| Day High | $10.41 | P/E | N/A | |||
| Day Low | $10.41 | EPS | $-0.30 | |||
| Volume | 8,596 | |||||
